Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
125.82
+2.53 (2.05%)
Nov 21, 2024, 1:34 PM EST - Market open
Neurocrine Biosciences Analyst Ratings
Total Analysts
24
Consensus Rating
Buy
Price Target
$163.91
Upside
+30.27%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $190 | Strong Buy | Reiterates | $190 | +51.01% | Nov 1, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 31, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 30, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 29, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $128 → $114 | Hold | Maintains | $128 → $114 | -9.39% | Oct 17, 2024 |
| Raymond James | Raymond James | Buy Initiates $155 | Buy | Initiates | $155 | +23.19% | Oct 10, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $133 | Hold | Reiterates | $133 | +5.71% | Oct 8, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $136 → $133 | Hold | Maintains | $136 → $133 | +5.71% | Oct 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $155 | Buy | Reiterates | $155 | +23.19% | Sep 16, 2024 |
| Barclays | Barclays | Buy Maintains $180 → $160 | Buy | Maintains | $180 → $160 | +27.17% | Sep 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $170 → $155 | Buy | Maintains | $170 → $155 | +23.19% | Aug 29, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $142 → $128 | Hold | Maintains | $142 → $128 | +1.73% | Aug 29, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $131 → $159 | Hold → Buy | Upgrades | $131 → $159 | +26.37% | Aug 29, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $143 → $136 | Hold | Maintains | $143 → $136 | +8.09% | Aug 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $190 | Strong Buy | Reiterates | $190 | +51.01% | Aug 29, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.